Abstract
We analyze how Japanese pharmaceutical firms internationalized their research and development (R&D) investments during the 1980 and 1990s. In order to tap into foreign knowledge bases, they heavily invested in setting up R&D centers abroad. However, knowledge transfer, evidenced by international patent applications, was very limited during the early phase of globalization. As a response, Japanese firms have shifted their R&D strategy toward a better organizational integration of their foreign units.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Innovation and Technology Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
